Biosimilar Market Report

Europe Biosimilar Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 14, 2019
  • PAGES：203
  • REPORT CODE：GMM319405
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Biosimilar market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.9% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Biosimilar Market Segmentations:

    By Player:

    • Biotech Pharma

    • Hospira (Novartis)

    • 3sbio

    • SANDOZ (NOVARTIS)

    • Changchun High Tech

    • CP Guojian Pharmacy

    • Gelgen Biopharma

    • MYLAN

    • Sun pharma

    • Teva Pharmaceutical

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Biosimilar Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Biosimilar Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Biosimilar Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Biosimilar Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Biosimilar Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Biosimilar Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Biosimilar Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biosimilar by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Biosimilar Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biosimilar by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biosimilar for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Biosimilar for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Biosimilar for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Biosimilar Production Analysis by Top Regions

    • 5.2 Europe Biosimilar Consumption Analysis by Top Regions

    • 5.3 Europe Biosimilar Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.3 France Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Production, Import, Consumption and Export Analysis

    6 Product Circulation of Biosimilar Market among Top Countries

    • 6.1 Top 5 Export Countries in Biosimilar Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Biosimilar Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Biosimilar Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biosimilar Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Biosimilar Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Biosimilar Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Biosimilar Landscape Analysis

    • 7.1 Germany Biosimilar Landscape Analysis by Major Types

    • 7.2 Germany Biosimilar Landscape Analysis by Major End-Users

    8. UK Biosimilar Landscape Analysis

    • 8.1 UK Biosimilar Landscape Analysis by Major Types

    • 8.2 UK Biosimilar Landscape Analysis by Major End-Users

    9. France Biosimilar Landscape Analysis

    • 9.1 France Biosimilar Landscape Analysis by Major Types

    • 9.2 France Biosimilar Landscape Analysis by Major End-Users

    10. Italy Biosimilar Landscape Analysis

    • 10.1 Italy Biosimilar Landscape Analysis by Major Types

    • 10.2 Italy Biosimilar Landscape Analysis by Major End-Users

    11. Spain Biosimilar Landscape Analysis

    • 11.1 Spain Biosimilar Landscape Analysis by Major Types

    • 11.2 Spain Biosimilar Landscape Analysis by Major End-Users

    12. Poland Biosimilar Landscape Analysis

    • 12.1 Poland Biosimilar Landscape Analysis by Major Types

    • 12.2 Poland Biosimilar Landscape Analysis by Major End-Users

    13. Russia Biosimilar Landscape Analysis

    • 13.1 Russia Biosimilar Landscape Analysis by Major Types

    • 13.2 Russia Biosimilar Landscape Analysis by Major End-Users

    14. Switzerland Biosimilar Landscape Analysis

    • 14.1 Switzerland Biosimilar Landscape Analysis by Major Types

    • 14.2 Switzerland Biosimilar Landscape Analysis by Major End-Users

    15. Turkey Biosimilar Landscape Analysis

    • 15.1 Turkey Biosimilar Landscape Analysis by Major Types

    • 15.2 Turkey Biosimilar Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Landscape Analysis by Top Countries

      • 16.3.1 Denmark Biosimilar Market Volume and Growth Rate

      • 16.3.2 Finland Biosimilar Market Volume and Growth Rate

      • 16.3.3 Norway Biosimilar Market Volume and Growth Rate

      • 16.3.4 Sweden Biosimilar Market Volume and Growth Rate

      • 16.3.6 Iceland Biosimilar Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Landscape Analysis by Top Countries

      • 17.3.1 Belgium Biosimilar Market Volume and Growth Rate

      • 17.3.2 Netherlands Biosimilar Market Volume and Growth Rate

      • 17.3.3 Luxembourg Biosimilar Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Landscape Analysis by Top Countries

      • 18.3.1 Estonia Biosimilar Market Volume and Growth Rate

      • 18.3.2 Latvia Biosimilar Market Volume and Growth Rate

      • 18.3.3 Lithuania Biosimilar Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Biotech Pharma

      • 19.1.1 Biotech Pharma Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Hospira (Novartis)

      • 19.2.1 Hospira (Novartis) Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 3sbio

      • 19.3.1 3sbio Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 SANDOZ (NOVARTIS)

      • 19.4.1 SANDOZ (NOVARTIS) Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Changchun High Tech

      • 19.5.1 Changchun High Tech Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 CP Guojian Pharmacy

      • 19.6.1 CP Guojian Pharmacy Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Gelgen Biopharma

      • 19.7.1 Gelgen Biopharma Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 MYLAN

      • 19.8.1 MYLAN Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Sun pharma

      • 19.9.1 Sun pharma Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Teva Pharmaceutical

      • 19.10.1 Teva Pharmaceutical Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 79 Figures and 143 Tables)

    • Figure Product Picture

    • Figure Europe Biosimilar Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Biosimilar Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Biosimilar Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Biosimilar Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Biosimilar Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Biosimilar Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure France Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Biosimilar Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biosimilar Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biosimilar

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biosimilar by Different Types from 2014 to 2026

    • Table Consumption Share of Biosimilar by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biosimilar by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biosimilar by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Biosimilar Production by Major Regions

    • Table Europe Biosimilar Production Share by Major Regions

    • Figure Europe Biosimilar Production Share by Major Countries and Regions in 2014

    • Table Europe Biosimilar Consumption by Major Regions

    • Table Europe Biosimilar Consumption Share by Major Regions

    • Table Germany Biosimilar Production, Import, Consumption and Export Analysis

    • Table UK Biosimilar Production, Import, Consumption and Export Analysis

    • Table France Biosimilar Production, Import, Consumption and Export Analysis

    • Table Italy Biosimilar Production, Import, Consumption and Export Analysis

    • Table Spain Biosimilar Production, Import, Consumption and Export Analysis

    • Table Poland Biosimilar Production, Import, Consumption and Export Analysis

    • Table Russia Biosimilar Production, Import, Consumption and Export Analysis

    • Table Switzerland Biosimilar Production, Import, Consumption and Export Analysis

    • Table Turkey Biosimilar Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biosimilar Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biosimilar Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biosimilar Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biosimilar Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Biosimilar Consumption by Types from 2014 to 2026

    • Table Germany Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Germany Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Germany Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table UK Biosimilar Consumption by Types from 2014 to 2026

    • Table UK Biosimilar Consumption Share by Types from 2014 to 2026

    • Table UK Biosimilar Consumption by End-Users from 2014 to 2026

    • Table UK Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table France Biosimilar Consumption by Types from 2014 to 2026

    • Table France Biosimilar Consumption Share by Types from 2014 to 2026

    • Table France Biosimilar Consumption by End-Users from 2014 to 2026

    • Table France Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Italy Biosimilar Consumption by Types from 2014 to 2026

    • Table Italy Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Italy Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Italy Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Spain Biosimilar Consumption by Types from 2014 to 2026

    • Table Spain Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Spain Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Spain Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Poland Biosimilar Consumption by Types from 2014 to 2026

    • Table Poland Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Poland Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Poland Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Russia Biosimilar Consumption by Types from 2014 to 2026

    • Table Russia Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Russia Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Russia Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Biosimilar Consumption by Types from 2014 to 2026

    • Table Switzerland Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Switzerland Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Switzerland Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Biosimilar Consumption by Types from 2014 to 2026

    • Table Turkey Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Turkey Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Turkey Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Biosimilar Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Biosimilar Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Biosimilar Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Biosimilar Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Biotech Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotech Pharma

    • Figure Sales and Growth Rate Analysis of Biotech Pharma

    • Figure Revenue and Market Share Analysis of Biotech Pharma

    • Table Product and Service Introduction of Biotech Pharma

    • Table Company Profile and Development Status of Hospira (Novartis)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira (Novartis)

    • Figure Sales and Growth Rate Analysis of Hospira (Novartis)

    • Figure Revenue and Market Share Analysis of Hospira (Novartis)

    • Table Product and Service Introduction of Hospira (Novartis)

    • Table Company Profile and Development Status of 3sbio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3sbio

    • Figure Sales and Growth Rate Analysis of 3sbio

    • Figure Revenue and Market Share Analysis of 3sbio

    • Table Product and Service Introduction of 3sbio

    • Table Company Profile and Development Status of SANDOZ (NOVARTIS)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SANDOZ (NOVARTIS)

    • Figure Sales and Growth Rate Analysis of SANDOZ (NOVARTIS)

    • Figure Revenue and Market Share Analysis of SANDOZ (NOVARTIS)

    • Table Product and Service Introduction of SANDOZ (NOVARTIS)

    • Table Company Profile and Development Status of Changchun High Tech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High Tech

    • Figure Sales and Growth Rate Analysis of Changchun High Tech

    • Figure Revenue and Market Share Analysis of Changchun High Tech

    • Table Product and Service Introduction of Changchun High Tech

    • Table Company Profile and Development Status of CP Guojian Pharmacy

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CP Guojian Pharmacy

    • Figure Sales and Growth Rate Analysis of CP Guojian Pharmacy

    • Figure Revenue and Market Share Analysis of CP Guojian Pharmacy

    • Table Product and Service Introduction of CP Guojian Pharmacy

    • Table Company Profile and Development Status of Gelgen Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gelgen Biopharma

    • Figure Sales and Growth Rate Analysis of Gelgen Biopharma

    • Figure Revenue and Market Share Analysis of Gelgen Biopharma

    • Table Product and Service Introduction of Gelgen Biopharma

    • Table Company Profile and Development Status of MYLAN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MYLAN

    • Figure Sales and Growth Rate Analysis of MYLAN

    • Figure Revenue and Market Share Analysis of MYLAN

    • Table Product and Service Introduction of MYLAN

    • Table Company Profile and Development Status of Sun pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun pharma

    • Figure Sales and Growth Rate Analysis of Sun pharma

    • Figure Revenue and Market Share Analysis of Sun pharma

    • Table Product and Service Introduction of Sun pharma

    • Table Company Profile and Development Status of Teva Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical

    • Table Product and Service Introduction of Teva Pharmaceutical

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US